USMAN JAVAID: Open Payments
NPI 1104919992 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 51 payments from 14 companies in 2025. Trend: 2023 $950 · 2024 $551 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| Lilly USA, LLC | 9 | $165 |
| ABBVIE INC. | 8 | $159 |
| PFIZER INC. | 10 | $154 |
| Exact Sciences Corporation | 3 | $49 |
| Tris Pharma Inc | 2 | $37 |
| Novo Nordisk Inc | 2 | $35 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
Products named: AIRSUPRA, NURTEC ODT, MOUNJARO, UBRELVY, JARDIANCE, QULIPTA, ELIQUIS, Dyanavel XR.
Industry payments across MO — which companies pay providers there.
